Panpan Dai
Hubei Key Laboratory Of Tumor Biological Behaviors
China
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy.
Journal: Cell research
Published: March 24, 2025
CDK10 suppresses nucleic acid sensors-mediated antitumor immunity.
Journal: Nature cancer
Published: March 03, 2025
USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2024
USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity.
Journal: Nature communications
Published: April 01, 2024
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.
Journal: Cell chemical biology
Published: October 11, 2022
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.
Journal: Nature communications
Published: September 28, 2022
PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy.
Journal: Cancer letters
Published: December 29, 2021
GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma.
Journal: Communications biology
Published: December 20, 2021
Establishment of the Prognostic Index Reflecting Tumor Immune Microenvironment of Lung Adenocarcinoma Based on Metabolism-Related Genes.
Journal: Journal of Cancer
Published: June 09, 2020
Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis.
Journal: Cancer cell international
Published: November 10, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026